GB0312832D0 - 2-amino-pyridine derivatives useful for the treatment of diseases - Google Patents

2-amino-pyridine derivatives useful for the treatment of diseases

Info

Publication number
GB0312832D0
GB0312832D0 GBGB0312832.9A GB0312832A GB0312832D0 GB 0312832 D0 GB0312832 D0 GB 0312832D0 GB 0312832 A GB0312832 A GB 0312832A GB 0312832 D0 GB0312832 D0 GB 0312832D0
Authority
GB
United Kingdom
Prior art keywords
diseases
amino
treatment
pyridine derivatives
derivatives useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0312832.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Pfizer Inc
Original Assignee
Pfizer Ltd Great Britain
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain, Pfizer Inc filed Critical Pfizer Ltd Great Britain
Priority to GBGB0312832.9A priority Critical patent/GB0312832D0/en
Publication of GB0312832D0 publication Critical patent/GB0312832D0/en
Priority to CA002527788A priority patent/CA2527788A1/en
Priority to EP04735621A priority patent/EP1633715B1/en
Priority to JP2006508431A priority patent/JP2006526613A/ja
Priority to AT04735621T priority patent/ATE372321T1/de
Priority to BRPI0410946-5A priority patent/BRPI0410946A/pt
Priority to DE602004008773T priority patent/DE602004008773T2/de
Priority to ES04735621T priority patent/ES2291882T3/es
Priority to MXPA05012840A priority patent/MXPA05012840A/es
Priority to PCT/IB2004/001850 priority patent/WO2004108676A1/en
Priority to PE2004000553A priority patent/PE20050628A1/es
Priority to UY28339A priority patent/UY28339A1/es
Priority to ARP040101904A priority patent/AR044475A1/es
Priority to PA20048604301A priority patent/PA8604301A1/es
Priority to TW093115990A priority patent/TW200524603A/zh
Priority to US10/860,772 priority patent/US7375100B2/en
Priority to NL1026329A priority patent/NL1026329C2/nl
Priority to GT200400116A priority patent/GT200400116A/es
Priority to CL200401366A priority patent/CL2004001366A1/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0312832.9A 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases Ceased GB0312832D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB0312832.9A GB0312832D0 (en) 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases
EP04735621A EP1633715B1 (en) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
MXPA05012840A MXPA05012840A (es) 2003-06-04 2004-06-01 Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades.
PE2004000553A PE20050628A1 (es) 2003-06-04 2004-06-01 DERIVADOS DE 2-AMINO-PIRIDINA COMO AGONISTAS ß-2
JP2006508431A JP2006526613A (ja) 2003-06-04 2004-06-01 β２−アドレナリン受容体アゴニストとしての２−（６−アミノ−ピリジン−３−イル）−２−ヒドロキシエチルアミン誘導体
AT04735621T ATE372321T1 (de) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamin- verbindungen als beta 2-adrenoceptoren agonisten
BRPI0410946-5A BRPI0410946A (pt) 2003-06-04 2004-06-01 derivados de 2-(6-amino-piridin-3-il)-2-hidroxietilamina como agonistas de receptores adrenérgicos beta 2
DE602004008773T DE602004008773T2 (de) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamin-verbindungen als beta 2-adrenoceptoren agonisten
ES04735621T ES2291882T3 (es) 2003-06-04 2004-06-01 Derivados de 2-(6-amino-piridin-3-il)-2-hidroxietilamina como agonistas de adrenoceptores beta 2.
CA002527788A CA2527788A1 (en) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
PCT/IB2004/001850 WO2004108676A1 (en) 2003-06-04 2004-06-01 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
UY28339A UY28339A1 (es) 2003-06-04 2004-06-02 Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
CL200401366A CL2004001366A1 (es) 2003-06-04 2004-06-03 Compuestos derivados de 2-(6-amino-piridin-2-il)-2-hidroxietilamino sustituidos, agonistas b2-adrenoceptores; procedimiento de preparacion; composicion farmaceutica; composicion farmaceutica y uso del compuesto en el tratamiento de asma, bronquitis c
ARP040101904A AR044475A1 (es) 2003-06-04 2004-06-03 Derivados de 2-amino -piridina utiles para el tratamiento de enfermedades
PA20048604301A PA8604301A1 (es) 2003-06-04 2004-06-03 Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
TW093115990A TW200524603A (en) 2003-06-04 2004-06-03 2-amino-pyridine derivatives useful for the treatment of diseases
US10/860,772 US7375100B2 (en) 2003-06-04 2004-06-03 2-amino-pyridine derivatives useful for the treatment of diseases
NL1026329A NL1026329C2 (nl) 2003-06-04 2004-06-03 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten.
GT200400116A GT200400116A (es) 2003-06-04 2004-06-03 Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0312832.9A GB0312832D0 (en) 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases

Publications (1)

Publication Number Publication Date
GB0312832D0 true GB0312832D0 (en) 2003-07-09

Family

ID=9959308

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0312832.9A Ceased GB0312832D0 (en) 2003-06-04 2003-06-04 2-amino-pyridine derivatives useful for the treatment of diseases

Country Status (18)

Country Link
EP (1) EP1633715B1 (https=)
JP (1) JP2006526613A (https=)
AR (1) AR044475A1 (https=)
AT (1) ATE372321T1 (https=)
BR (1) BRPI0410946A (https=)
CA (1) CA2527788A1 (https=)
CL (1) CL2004001366A1 (https=)
DE (1) DE602004008773T2 (https=)
ES (1) ES2291882T3 (https=)
GB (1) GB0312832D0 (https=)
GT (1) GT200400116A (https=)
MX (1) MXPA05012840A (https=)
NL (1) NL1026329C2 (https=)
PA (1) PA8604301A1 (https=)
PE (1) PE20050628A1 (https=)
TW (1) TW200524603A (https=)
UY (1) UY28339A1 (https=)
WO (1) WO2004108676A1 (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
AR051091A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1807085B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580762A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
AU2005286648A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
BRPI0614290A2 (pt) 2005-08-08 2011-03-22 Argenta Discovery Ltd derivados de biciclo [ 2.2.1 ] hept-7-ilamina e seus usos
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
RU2421464C2 (ru) 2005-10-21 2011-06-20 Новартис Аг Человеческие антитела к il-13 и их терапевтическое применение
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP2322525B1 (en) 2006-04-21 2013-09-18 Novartis AG Purine derivatives for use as adenosin A2A receptor agonists
PL2035004T3 (pl) * 2006-06-09 2013-01-31 Parion Sciences Inc Podstawione fenylem pirazynoiloguanidynowe blokery kanału sodowego o aktywności beta-agonistycznej
EP2077262A4 (en) 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
DE602008005140D1 (de) 2007-05-07 2011-04-07 Novartis Ag Organische verbindungen
MX2010006421A (es) 2007-12-10 2010-06-25 Novartis Ag Compuestos organicos.
MX2010007604A (es) 2008-01-11 2010-08-02 Novartis Ag Pirimidinas como inhibidores de cinasa.
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
JP2011522860A (ja) 2008-06-10 2011-08-04 ノバルティス アーゲー 上皮性ナトリウムチャネルブロッカーとしてのピラジン誘導体
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
DE102008049675A1 (de) 2008-09-30 2010-04-01 Markus Dr. Heinrich Verfahren zur Herstellung von 3-Aminobiphenylen
ES2442343T3 (es) 2008-12-30 2014-02-11 Pulmagen Therapeutics (Inflammation) Limited Compuestos de sulfonamida para el tratamiento de trastornos respiratorios
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
MX2012004792A (es) 2009-10-22 2013-02-01 Vertex Pharma Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
WO2012116217A1 (en) 2011-02-25 2012-08-30 Irm Llc Compounds and compositions as trk inhibitors
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
CN103946221B (zh) 2011-09-16 2016-08-03 诺华股份有限公司 用于治疗囊性纤维化的杂环化合物
US9056867B2 (en) 2011-09-16 2015-06-16 Novartis Ag N-substituted heterocyclyl carboxamides
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
EP3134397A1 (en) 2014-04-24 2017-03-01 Novartis AG Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
KR20160141856A (ko) 2014-04-24 2016-12-09 노파르티스 아게 포스파티딜이노시톨 3-키나제 억제제로서의 피라진 유도체
KR20160145780A (ko) 2014-04-24 2016-12-20 노파르티스 아게 포스파티딜이노시톨 3-키나제 억제제로서의 아미노 피리딘 유도체
WO2020250116A1 (en) 2019-06-10 2020-12-17 Novartis Ag Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis
PE20220346A1 (es) 2019-08-28 2022-03-14 Novartis Ag Derivados de 1,3-fenil heteroarilo sustituidos y su uso en el tratamiento de enfermedades

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
CA2220399A1 (en) * 1995-05-10 1996-11-14 Pfizer Inc. .beta.-adrenergic agonists
EP1078924B1 (en) * 1999-07-23 2004-10-20 Pfizer Products Inc. Intermediates and a process for producing beta-adrenergic receptor agonists
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
GB0217225D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
EP1556034B1 (en) * 2002-10-11 2008-04-16 Pfizer Limited Indole derivatives as beta-2 agonists

Also Published As

Publication number Publication date
PE20050628A1 (es) 2005-08-30
PA8604301A1 (es) 2004-12-16
WO2004108676A1 (en) 2004-12-16
NL1026329C2 (nl) 2005-07-26
GT200400116A (es) 2005-03-03
AR044475A1 (es) 2005-09-14
CA2527788A1 (en) 2004-12-16
BRPI0410946A (pt) 2006-06-27
MXPA05012840A (es) 2006-02-13
JP2006526613A (ja) 2006-11-24
ES2291882T3 (es) 2008-03-01
EP1633715A1 (en) 2006-03-15
ATE372321T1 (de) 2007-09-15
NL1026329A1 (nl) 2004-12-07
EP1633715B1 (en) 2007-09-05
DE602004008773D1 (de) 2007-10-18
TW200524603A (en) 2005-08-01
DE602004008773T2 (de) 2008-01-10
UY28339A1 (es) 2005-01-31
CL2004001366A1 (es) 2005-05-06

Similar Documents

Publication Publication Date Title
GB0312832D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
PL1633726T3 (pl) Pochodne pirymidyny użyteczne w leczeniu chorób w których pośredniczy CRTH2
AP2005003283A0 (en) Indole derivatives useful for the treatment os diseases
SI1830843T1 (sl) Indolinonski derivati za zdravljenje ali preprečevanje fibroznih bolezni
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
NL1026327A1 (nl) 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten.
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
IL176629A0 (en) Sulfonamide derivatives for the treatment of diseases
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
GB0329874D0 (en) Compounds useful for the treatment of diseases
SI1685125T1 (sl) Derivati pirola, primerni za zdravljenje proliferativnih bolezni
SI1487828T1 (sl) Morfolinil-sečninski derivati za uporabo pri zdravljenu vnetnih bolezni
PL377164A1 (pl) Pochodne anilinopirazolu przydatne do leczenia cukrzycy
IL176472A (en) Process for the preparation of pyridine derivatives
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
GB0201025D0 (en) The treatment of degenerative diseases
GB0312840D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
GB0312842D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
GB0217205D0 (en) 2-Amino-pyridine derivatives useful for the treatment of diseases
AU2003232844A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
ZA200606780B (en) Compounds for the treatment of diseases
GB0425054D0 (en) Formamide derivatives for the treatment of diseases
IL175611A0 (en) Combinations for the treatment of proliferative diseases
HK1071754A (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)